Research
G3BP1-induced retrograde transport blockade triggers HSC activation and liver fibrosis via COPI alternative splicing
The Brief
- Liver fibrosis is driven by hepatic stellate cell activation, and its molecular drivers are not fully understood.
- The study reports that G3BP1 promotes COPI alternative splicing via SRPK1–hnRNPM.
- The authors describe a G3BP1-induced retrograde transport blockade that triggers stellate cell activation and liver fibrosis.
Why it matters
The work proposes a molecular pathway linking a transport blockade and splicing changes to stellate cell activation, which may help researchers understand how liver fibrosis develops.
Who’s affected
- researchers studying liver fibrosis, hepatic stellate cells and intracellular transport
- #liver fibrosis
- #hepatic stellate cells
- #g3bp1
- #copi
- #alternative splicing
Nature Communications, Published online: 21 November 2026; doi:10.1038/s41467-026-79478-6 Liver fibrosis is driven by hepatic stellate cell activation, but its molecular drivers remain unclear. Here, the authors show that G3BP1 promotes COPI alternative splicing via SRPK1–hnRNPM…